| Stage | SCI | % of rev | CSV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $103M | 100.00% | SCI ×10.76 |
| Gross profit | $272M | 24.59% | $35M | 34.04% | CSV +9.5pp |
| Operating income | $253M | 22.84% | $24M | 23.27% | CSV +0.4pp |
| Pre-tax income | $189M | 17.05% | $17M | 16.67% | SCI +0.4pp |
| Net income | $141M | 12.76% | $12M | 11.92% | SCI +0.8pp |
| Stage | SCI | CSV | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $103M100.00% | SCI ×10.76 |
| Gross profit | 24.59%$272M | 34.04%$35M | CSV +9.5pp |
| Operating income | 22.84%$253M | 23.27%$24M | CSV +0.4pp |
| Pre-tax income | 17.05%$189M | 16.67%$17M | SCI +0.4pp |
| Net income |
None
No disclosed counterparties: SCI.
| 12.76%$141M |
| 11.92%$12M |
| SCI +0.8pp |